Qinyong Hu
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 1%
- Long-Term Effects of COVID-19
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 8
- COVID-19 and healthcare impacts 5
- Cancer Cells and Metastasis 3
-
- Single-cell and spatial transcriptomics 4
- Co-authors
- Runsheng Wang (6 shared papers)Guogang Xu (7 shared papers)Lei Tu (4 shared papers)Chao Hu (5 shared papers)Yingzhen Du (4 shared papers)Tianzhi Li (3 shared papers)Pengcheng Yang (5 shared papers)Mi Mu (2 shared papers)
- Journals
- Cancer Cell International (4 papers)Journal of Translational Medicine (2 papers)Frontiers in Oncology (2 papers)Journal of Cancer (1 paper)Clinical and Translational Gastroenterology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Qinyong Hu
34 papers receiving 2.4k citations
Qinyong Hu's Hit Papers
Peers
Comparison fields: 5 of 135
- Infectious Diseases 1.6k
- Neurology 844
- Critical Care and Intensive Care Medicine 110
- Oncology 502
- Modeling and Simulation 82
Countries citing papers authored by Qinyong Hu
This map shows the geographic impact of Qinyong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinyong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinyong Hu more than expected).
Fields of papers citing papers by Qinyong Hu
This network shows the impact of papers produced by Qinyong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinyong Hu. The network helps show where Qinyong Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Qinyong Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study Hit paper breakdown → | 2020 | 1234 |
| 2 | Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study Hit paper breakdown → | 2020 | 642 |
| 3 | 2020 | 142 | |
| 4 | 2021 | 102 | |
| 5 | 2021 | 62 | |
| 6 | 2024 | 36 | |
| 7 | 2015 | 32 | |
| 8 | 2008 | 27 | |
| 9 | 2020 | 24 | |
| 10 | 2019 | 23 | |
| 11 | 2019 | 21 | |
| 12 | 2023 | 19 | |
| 13 | 2022 | 16 | |
| 14 | 2015 | 14 | |
| 15 | 2024 | 13 | |
| 16 | 2016 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2020 | 11 | |
| 19 | 2023 | 10 | |
| 20 | 2019 | 9 |
About Qinyong Hu
Qinyong Hu is a scholar working on Oncology, Molecular Biology, Infectious Diseases, Immunology and Cancer Research, having authored 35 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), COVID-19 Clinical Research Studies (8 papers), COVID-19 and healthcare impacts (5 papers), Long-Term Effects of COVID-19 (4 papers), Immunotherapy and Immune Responses (4 papers), Single-cell and spatial transcriptomics (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Neurology (844 citations), Critical Care and Intensive Care Medicine (110 citations), Oncology (502 citations) and Modeling and Simulation (82 citations). Qinyong Hu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Runsheng Wang, Guogang Xu, Lei Tu, Chao Hu, Yingzhen Du, Tianzhi Li, Pengcheng Yang, Mi Mu, Yu Sun and Jun‐Hong Yan. Their work appears in journals such as Cancer Cell International, Journal of Translational Medicine, Frontiers in Oncology, Journal of Cancer and Clinical and Translational Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.